New York State Common Retirement Fund Acquires New Shares in Grail, Inc. (NASDAQ:GRAL)

New York State Common Retirement Fund acquired a new stake in Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 3,296 shares of the company’s stock, valued at approximately $59,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. abrdn plc acquired a new position in Grail during the 4th quarter worth $3,768,000. Douglas Lane & Associates LLC acquired a new position in Grail during the 4th quarter worth $3,034,000. Slow Capital Inc. acquired a new position in Grail during the 4th quarter worth $2,379,000. 180 Wealth Advisors LLC acquired a new position in Grail during the 4th quarter worth $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new position in Grail during the 4th quarter worth $559,000.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on GRAL. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock.

Grail Stock Performance

NASDAQ:GRAL opened at $33.45 on Friday. The firm’s 50-day moving average is $30.38 and its 200-day moving average is $20.69. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.

Grail (NASDAQ:GRAL) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. Sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.